[Changes in bacterial infections due to the development of chemotherapy presentation of methicillin resistant Staphylococcus aureus (MRSA)].
Takeuchi
Y
Y
Department of microbiology and Immunology, Nippon Medical School.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000517:prevention & control; D006801:Humans; D016106:Methicillin Resistance / Q000235:genetics; D009154:Mutation; D013203:Staphylococcal Infections / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D013997:Time Factors
D000900:Anti-Bacterial Agents